OUR INVESTORS

Source: Mimi’s Rock Corp.

TORONTO, January 8, 2020 – Mimi’s Rock Corp. (‘Mimi’s Rock’ or the ‘Company’) (TSXV:MIMI) an online dietary supplement and wellness company operating the Dr. Tobias, All Natural Advice and Maritime Naturals brands, is pleased to announce the Company has entered into an exclusive agreement with WestGoods Inc. (the “Buyer”) for the sale of our brands in The People’s Republic of China.

The Supply Agreement with the Buyer is for a term of five years and includes minimum sales requirements for the Buyer to maintain the license. WestGoods Inc. has been successfully distributing the recently-acquired All Natural Advice products for the past six months and will now expand distribution with the sale of our Dr. Tobias and Maritime Naturals lines.

‘We have promised our shareholders consistent expansion of distribution channels and we continue to meet that commitment. When we acquired the Dr. Tobias brand eighteen months ago, our sales were to the US market only. Our product lines are now sold in the US, Canada, Germany the UK, Italy, Australia and China’ said Dave Kohler, CEO of Mimi’s Rock.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About Mimi’s Rock Corp.

Mimi’s Rock Corp. is an online dietary supplement and wellness company which operates the Dr. Tobias, All Natural Advice and Maritime Naturals brands. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. The Omega 3 Fish Oil is also the 4th largest subscribe & save product on Amazon.com. Mimi’s Rock has rapid growth plans to continue to expand into global markets. For more information, visit Mimisrock.com.

Forward-Looking Information.

This news release includes ‘forward-looking information,’ as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of Bloom Burton and its conference, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO

905-330-5081

[email protected]

Telfer Hanson, Executive Chairman

416-230-3003

[email protected]

Source: Mimi’s Rock Corp.

(Toronto: December 16, 2019) Mimi’s Rock Corp. (‘Mimi’s Rock’ or the ‘Company’) (TSXV:MIMI), is pleased to announce a new line of nutritional supplements, launched under the brand ‘LENNOX by Dr Tobias’, is now available in the United States on Amazon.com, and on drtobias.com

Lennox Lewis is a former professional boxer who competed from 1989 to 2003. He is a three-time world heavyweight champion, a two-time lineal champion, and remains the last heavyweight to hold the undisputed title. Holding dual British and Canadian citizenship, Lewis represented Canada as an amateur in the 1988 Summer Olympics, winning a gold medal in the super-heavyweight division.

‘We have been working with Lennox to formulate three unique daily multipack supplements for Performance, Daily Essentials and Joint Support. These multi-packs make it convenient to ensure athletes – and former athletes – are getting a great daily supplement mix, which supports their needs. Lennox has a deep personal interest in not just maintaining health, but pushing for improvements as he ages. The Lennox and Mimi’s Rock teams are dedicated to creating products that will allow others to do the same’ said Dave Kohler, CEO of Mimi’s Rock.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About Mimi’s Rock Corp.

Mimi’s Rock Corp. is an online dietary supplement and wellness company which operates the Dr. Tobias brand. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. The Omega 3 Fish Oil is also the 4th largest subscribe & save product on Amazon.com. Mimi’s Rock currently serves customers in the United States and Canada, and has rapid growth plans to expand into other markets. For more information, visit https://mimisrock.com.

Forward-Looking Information

This news release includes ‘forward-looking information,’ as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of Bloom Burton and its conference, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO

905-330-5081

[email protected]

Telfer Hanson, Executive Chairman

416-230-3003

[email protected]

Source: Mimi’s Rock Corp.

(Toronto: December 13, 2019) Mimi’s Rock Corp. (‘Mimi’s Rock’ or the ‘Company’) (TSXV:MIMI) is pleased to announce the successful completion of its previously-announced acquisition of All Natural Advice Ltd. (‘All Natural’) and Maritime Naturals Ltd. (‘Maritime Naturals’) by way of a share purchase transaction. Combined, the acquired businesses generated approximately $5.5 million of revenue and $1.6 million of EBITDA over the past twelve months, with consolidated revenue growing 29% year over year and EBITDA growth of 109% on a year over year basis. In connection with the transaction, the Company has renegotiated its senior credit facility, providing cash for the acquisition while reducing borrowing costs.

‘This acquisition is not only immediately accretive, it is also an excellent strategic fit for Mimi’s Rock Corp. All Natural Advice has business in several European countries which were future target markets for us. This allows us to accelerate our strategy’ said Dave Kohler, CEO of Mimi’s Rock.

The purchase price was satisfied by (i) payment, in aggregate, of approximately $5.5 million in cash, (ii) the issuance of an aggregate of 3,203,048 common shares in the capital of Mimi’s Rock, 75% of which will remain still subject to escrow, and (iii) the assumption of a loan from the vendors in the amount of approximately $2 million, which loan is to be repaid within 12 months of closing. The cash portion of the purchase price is paid with a combination of cash on hand and additional borrowings under the Company’s long-term debt facility with the Bank of Nova Scotia, the terms of which was amended and restated on December 13, 2019.

All Natural and Maritime Naturals currently offer products in Germany, Italy, UK and Australia, giving Mimi’s Rock immediate access to these markets. The Company believes that their products will allow Mimi’s Rock to offer 45 additional SKUs to its already impressive basket of products by offering anti-ageing organic skincare products, all-natural masks & scrubs, acne blemish treatments, beard oils and more.

Senior Debt Refinancing.

On December 13, 2019, the Company modified its secured debt facility, as originally entered into on July 6, 2018. The revised facility matures on December 13, 2022 and provides for a $16,632,000 term loan repayable over four years, initially at the Canadian Bankers’ Acceptance (“BA”) rate plus 3.0%, or approximately 4.95% effective rate, with quarterly payments of principal and interest beginning March 2020. The revised credit facility also continues to provide for an operating line of credit, secured by inventory and accounts receivable, as well as corporate credit cards. Importantly, the requirement that the Company insure its debt with Export Development Canada has been removed, lowering the Company’s overall cost of capital.

The facility is secured by all assets of the Company and contains affirmative and negative covenants including compliance with laws and restrictions on additional debt, as well as traditional financial covenants such as debt to earnings and other coverage ratios. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Natural Advice and Maritime Naturals.

All Natural Advice and Maritime Naturals, based in Ontario and Nova Scotia, respectively, are companies focused on skin and beauty care. Products sold by All Natural and Maritime Naturals are made in Canada and registered under Health Canada and under the EU Cosmetics Act. Together, All Natural and Maritime Naturals have over 45 products in jurisdictions around the world. All Natural has been featured on BNN as a top selling skincare brand in Canada and has been rated the #1 Beauty Brand on Amazon Canada for the past 4 years.

About Mimi’s Rock Corp.

Mimi’s Rock Corp. is an online dietary supplement and wellness company operating under the Dr. Tobias brand. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. The Company currently serves customers in the United States and has rapid growth plans to expand into other markets.

Forward Looking Statements

This news release may contain forward-looking statements or ‘forward-looking information’ within the meaning of applicable Canadian securities laws (‘forward-looking statements’). Often, but not always, forward-looking statements can be identified by the use of words such as ‘plans’, ‘expects’ or ‘does not expect’, ‘is expected’, ‘budget’, ‘scheduled’, ‘estimates’, ‘forecasts’, ‘intends’, ‘anticipates’ or ‘does not anticipate’, or ‘believes’, or describes a ‘goal’, or variation of such words and phrases or state that certain actions, events or results ‘may’, ‘could’, ‘would’, ‘might’ or ‘will’ be taken, occur or be achieved.

All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements. Forward-looking statements involve known and unknown risks, future events, conditions, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, prediction, projection, forecast, performance or achievements expressed or implied by the forward-looking statements. Such factors include, among others, internal and external factors disclosed in the most recent annual information form of the Company and other documents publicly filed by the Company. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act’) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

For more information, please visit Mimisrock.com

For further information, please contact:

Telfer Hanson

416 230 3003

[email protected]

Source: Mimi’s Rock Corp.

TORONTO, November 28, 2019 – Mimi’s Rock Corp. (TSXV:MIMI) “The Company”, an online dietary supplement and wellness company operating the Dr. Tobias brand, today announced its financial results for the quarter ended September 30, 2019.

Recent Developments

• On September 5, 2019, the Company announced it had entered into binding agreements to acquire two additional businesses. Agreements to acquire All Natural Advice Ltd. (‘All Natural’) and Maritime Naturals Ltd. (‘Maritime Naturals’) are expected to be completed shortly. All Natural is the #1 Skin Care Seller on Amazon Canada for the past 4 years. Mimi’s Rock will acquire all of the issued and outstanding shares of each of All Natural and Maritime Naturals for an aggregate purchase price of approximately $9.6 million. The acquisition of these accretive businesses will add approximately $5.5 million of combined revenue and $1.6 million of EBITDA. Closing for both acquisitions is scheduled for December 10, 2019.
• On September 24, 2019, the Company announced (further to the joint venture announcement of July 8, 2019) the execution of a definitive agreement with three-time world heavyweight champion Lennox Lewis to develop and commercialize a new line of branded nutritional supplements. The co-branded supplements will focus on men’s health and wellness and will feature products such as a Men’s Multipack Vitamin. Products will be sold exclusively online.
• On November 13, 2019, the Company announced the launch of its Dr. Tobias line of dietary supplements in Canada. Initially, Dr Tobias will be launching the brand’s top-rated Omega 3 Fish Oil, known to support cardiovascular health, cognitive health and brain function, and its Multivitamin, a product which promotes eye, skin, membrane, and immune function and fosters strong bones and teeth. These product launches have been made available on Amazon.ca and on the e-commerce platform drtobias.com.
• On November 27, 2019, the Company announced that the TSX Venture Exchange has accepted the Company’s notice to implement a normal course issuer bid (‘NCIB’) to purchase, for cancellation, up to 3,029,109 of its common shares, representing approximately 10% of the Company’s ‘public float’. Management of the Company believes that the Shares have been trading in a price range which does not adequately reflect their value and that the purchase of the Shares under the NCIB is in the best interests of the Company, a desirable use of its available cash, and will enhance shareholder value in general.

Dave Kohler, CEO of Mimi’s Rock commented, ‘We are excited to be launching multiple new products and categories in new markets. These, coupled with the pending acquisition of All Natural and Maritime Naturals, give us access to new revenue streams and offer diversification from the single-market roots of the organization. As we continue to execute our strategies, these markets should contribute significantly to our growth’.

Results of Operations.

For the three months ended September 30, 2019, the Company incurred a net loss of $243,156 compared to a net loss of $759,537 for the three months ended September 30, 2018. For the three months ended September 30, 2019, EBITDA was $626,540, compared to EBITDA of $216,887 for the three months ended September 30, 2018. Adjusted EBITDA, which excludes non-cash share based compensation expense, investment income, listing expenses and acquisition costs, was $902,776, compared to Adjusted EBITDA of $1,530,973 for the same period in the prior year. For the nine months ended September 30, 2019, the Company incurred a net loss of $1,091,290 ($0.03 per share), compared to a net loss of $759,537 ($0.05 per share) for the nine month period ended September 30, 2018. EBITDA for the nine months ended September 30, 2019 was $2,184,461, compared to $216,887 EBITDA for the same period in the prior year. Adjusted EBITDA was $3,603,413 for the nine months ended September 30, 2019, compared to $1,530,973 for the same period in 2018.

The Company reported a net loss for the three and nine months ended September 30, 2019 primarily due to one- time costs related to its reverse takeover and public listing expenses as part of the Qualifying Transaction completed in May 2019, as well as non-cash share-based compensation expense. Tax expense in the nine month period was also higher than normal due to derecognition of tax loss carryforwards in Germany as a result of the reverse acquisition.

Revenues for the three months ended September 30, 2019 were $8,755,114 compared to revenues of $8,522,950 for the three month period ended September 30, 2018. Revenues represent sales of nutraceutical products in the U.S. market. Gross margin for the three months ended September 30, 2019 was $6,114,962 (70%) compared to $5,553,930 (65%) for the three month period ended September 30, 2018. Gross margin ratios have improved over the comparative period as the Company works with its supplier to obtain better pricing and efficiencies. Revenues were $27,692,245 for the nine months ended September 30, 2019 compared to revenues of $8,522,950 for the nine months ended September 30, 2018. Revenues reported in the current and prior year primarily represent revenues from the DTI business, which began to accrue to the Company from July 13, 2018, the date of acquisition. Revenues from the core business have remained strong with some seasonality. The Company has begun to add additional sales channels through the launch of its own e-commerce site and sales to other e- commerce outlets. Going forward, growth is expected to come from launch of product sales in additional geographic regions as well as other online portals.

The Company continues to adapt and further its brand strategy. Online advertising in the period was increased with a focus on brand awareness and customer loyalty. Sales from its own e-commerce site, drtobias.com, as well through additional online retail outlets continued to grow, however, a majority of revenue continues to be generated on the Amazon.com platform.

The Company incurred selling and marketing expenses of $4,014,971, or approximately 46% of revenue, for the three months ended September 30, 2019, compared to $3,300,945, or 39% of revenue, for the three months ended September 30, 2018. Advertising spend in the third quarter of 2019 was increased with a deliberate focus on attracting longer term repeat customers. While the brand continues to generate strong repeat sales, investments are also being made attract new-to-brand customers. While this type of ad spend does not necessarily translate to immediate revenue, it is important to the overall brand growth strategy. Sales and marketing expenses for the period consist primarily of fulfillment costs related to delivering products to customers, direct online advertising placements, costs related to marketing the Dr. Tobias brand and other promotional and awareness initiatives. The Company will continue to actively monitor its selling and marketing expenses, particularly those directly related to advertising and expects that these will vary in relation to sales revenues going forward as advertising spend is optimized relative to competitive conditions.

General and administrative expenses for the three months ended September 30, 2019 were $1,197,215, compared to $722,012 for the same period in 2018. General and administrative expenses consist primarily of salaries and benefits, professional fees, occupancy costs and insurance. General and administrative expenses in the 2019 period are higher than the same period in 2018 primarily due to higher overall staff levels and considerably more operational activity. Share based compensation expense for the three months ended September 30, 2019 was $123,747 compared to $326,685 for the three months ended September 30, 2018. Share based compensation expense in 2018 was considerably higher due to initial vesting of original employee grants. Share based compensation expense relates to awards under the Company’s incentive stock option plan and is based on the estimated number of awards that will eventually vest using the Black-Scholes option pricing model.

On May 27, 2019, the Company completed its Qualifying Transaction pursuant to an amalgamation agreement between the Company and Mimi’s Rock Inc. The Qualifying Transaction constituted a reverse take-over (‘RTO’) for accounting purposes, as former MRI shareholders hold a majority of outstanding shares in the Company, the Board of Directors is comprised of MRI Board members and the senior management of MRI became senior management of the Company. Listing expenses related to the acquisition and reverse takeover transaction were $786,138, compared to $nil for the same period in the prior year. Listing expenses consistprimarily of legal, accounting and other professional fees associated with the reverse takeover and amalgamation, as well as non-cash costs related to equity instruments issued for the acquisition.

Interest and financing costs of $426,409 were incurred during the three months ended September 30, 2019, compared to $447,076 for the three months ended September 30, 2018. Interest and financing expenses in the 2019 period include approximately $183,543 (2018: $137,106) in non-cash charges related to amortization of expenses incurred in securing the Company’s senior secured loan.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company operating under the Dr. Tobias brand. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. Mimi’s Rock currently serves customers in the United States and has rapid growth plans to expand into other markets. For more information, visit Mimisrock.com.

Forward-Looking Information

This news release includes “forward-looking information,” as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO

905-350-5081

[email protected]

Source: Canada Newswire

Mimi’s Rock Corp. (‘MR’ or ‘the Company’) (TSXV: MIMI), an online dietary supplement and wellness business, is pleased to announce the launch of its Dr. Tobias line of dietary supplements in Canada.

The first of the Dr. Tobias supplements are now available both via the drtobias.com e-commerce platform and on Amazon.ca. These will be followed by a cadence of additional products in the weeks and months ahead. Initially, Dr Tobias will be launching the brand’s top-rated Omega 3 Fish Oil, known to support cardiovascular health, cognitive health and brain function, and its Multivitamin, a product which promotes eye, skin, membrane, and immune function and fosters strong bones and teeth.

‘We are thrilled to be launching our Dr. Tobias brand in Canada. This marks our first new international market entrance for our business, beyond our primary marketplace (the USA) and is an important step in the execution of our planned multinational expansion. This product launch in Canada further demonstrates our team’s ability to execute on our strategies and to bring our diversified products and brands to a virtually unlimited global market,’ said David Kohler, CEO of Mimi’s Rock Corp.

These product launches have been made available on Amazon.ca and on the e-commerce platform drtobias.com.

About Mimi’s Rock Corp.:.

Mimi’s Rock Corp. is an online dietary supplement and wellness company under which the Dr. Tobias brand is operated. The brand features more than 30 products, including the top-selling Colon Cleanse and the number-one selling Omega 3 Fish Oil, which is also the 4th largest Subscribe and Save product on Amazon.com. Mimi’s Rock now serves customers in the United States through Amazon.com, Walmart.com, and Dr. Tobias.com, and in Canada through Amazon.ca and Drtobias.com, with a plan for rapid growth and expansion into other markets. For more information, visit https://mimisrock.com.

Forward-Looking Information

This news release includes ‘forward-looking information,’ as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of Bloom Burton and its conference, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

View original content: Newswire.ca/News-Release

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO

905-350-5081

[email protected]

Source: Canada Newswire

Mimi’s Rock Corp. (TSXV:MIMI) ‘The Company’, an online dietary supplement and wellness company operating the Dr. Tobias brand, is pleased to announce, further to the joint venture announcement of July 8, 2019, the execution of a definitive agreement with three-time world heavyweight champion Lennox Lewis to develop and commercialize a new line of branded nutritional supplements.

The co-branded supplements will focus on men’s health and wellness, and will feature products such as a Men’s Multipack Vitamin. Products will be sold exclusively online.

Lennox will provide social media and marketing support in respect of the products, which will bear his name and likeness, and be co-branded with Dr. Tobias, leveraging the strength of the Dr. Tobias products with Lennox Lewis’ reputation and celebrity as well as his significant following.

About Lennox Lewis:

Lennox Lewis, CM, CBE, nicknamed ‘The Lion’, is a retired professional boxer who remains the last heavyweight to hold the undisputed title. He competed from 1989 to 2003, and is a three-time world heavyweight champion and two-time Lineal champion. Holding dual British and Canadian citizenship, Lewis represented Canada as an amateur in the 1988 Summer Olympics, winning a gold medal in the super-heavyweight division.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company operating under the Dr. Tobias brand. The brand features over 30 products including the top selling Colon Cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. The Omega 3 Fish Oil is also the 4th largest subscribe & save product on Amazon.com. Mimi’s Rock currently serves customers in the United States through Amazon.com, Walmart.com, and Dr. Tobias.com, with a rapid growth plan to expand into other markets. For more information, visit Mimisrock.com.

Forward-Looking Information

This news release includes ‘forward-looking information,’ as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of Bloom Burton and its conference, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

View original content: Newswire.ca/News-Release

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO

905-350-5081

[email protected]

Source: Canada NewsWire

TORONTO, Sept. 5, 2019 /CNW/ – Mimi’s Rock Corp. (‘Mimi’s Rock’ or ‘the Company’) (TSXV: MIMI), an online dietary supplement and wellness business, is pleased to announce it has entered into binding agreements to acquire two additional businesses, namely All Natural Advice Ltd. (‘All Natural’) and Maritime Naturals Ltd. (‘Maritime Naturals’). All Natural is the #1 Skin Care Seller on Amazon Canada for the past 4 years. Mimi’s Rock will acquire all of the issued and outstanding shares of each of All Natural and Maritime Naturals for an aggregate purchase price of $9,636,000. The acquisition of these accretive businesses will fold in the #1 seller of skincare products on Amazon Canada, adding approximately $5.5 million of revenue and $1.6 million of EBITDA. Combined, these two companies delivered a 54% compound annual growth rate over the last five years, with no debt.

‘We are very excited to add the All Natural and Maritime Naturals brands to our portfolio. These companies have a history of strong financial performance and will immediately open additional markets for us. The brand exposure and potential for cross-selling to existing customers will be a great benefit,’ says Mimi’s Rock CEO, David Kohler. ‘Access to the premium organic and all-natural beauty segment is a great fit for our company and aligns with our wellness-seeking clientele.’

The purchase price will be satisfied by (i) the payment, in aggregate, of approximately $5.5 million in cash, (ii) the issuance of common shares in the capital of Mimi’s Rock valued at approximately $2.1 million, and (iii) the assumption of a $2 million vendor loan to be repaid within 12 months of closing. The cash portion of the purchase price is expected to be paid from a combination of cash on hand and additional borrowings under a modification of the Company’s long term debt facilities. Further details will be provided in a subsequent news release once determined. Subject to the satisfaction of customary closing conditions, including the execution of definitive agreements and receipt of approval from the TSX Venture Exchange, the acquisitions are expected to close on or about October 15, 2019.

Dave Kohler, CEO of Mimi’s Rock commented, “We are pleased that during the quarter, we executed three important strategic initiatives as planned. We added a new product family and opened a new online channel, in addition to launching our own e-Commerce site. Together, these accomplishments position us well to execute our scaling and expansionary plans.”

Combined Acquisition Highlights:

• #1 seller of skincare products on Amazon Canada
• ~$5.5M revenue
• ~$1.6M EBITDA
• 54% CAGR over 5 years
• 45 SKUs
• Operational in multiple jurisdictions

All Natural and Maritime Naturals currently offer products in Germany, Italy, UK and Australia, giving Mimi’s Rock immediate access to these markets. Their products will allow Mimi’s Rock to offer 45 additional SKUs to its already impressive basket of products by offering anti-aging organic skincare products, all-natural masks & scrubs, acne blemish treatments, beard oils and more..

About All Natural Advice & Maritime Naturals.

All Natural Advice and Maritime Naturals, based in Ontario and Nova Scotia, respectively, are companies focused on skin and beauty care. Products sold by All Natural and Maritime Naturals are made in Canada and registered with Health Canada and under the EU Cosmetics Act. Together, All Natural and Maritime Naturals have over 45 products in jurisdictions around the world. All Natural has been featured on BNN as a top selling skincare brand in Canada and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

About Mimi’s Rock Corp.

Mimi’s Rock Corp. is an online dietary supplement and wellness company. The leading brand of Mimi’s Rock is Dr. Tobias, which features more than 30 products, including the top-selling Colon Cleanse and the #1 selling Omega 3 Fish Oil, which is also the fourth largest Subscribe and Save product on Amazon.com. Mimi’s Rock currently serves customers in the United States through Amazon.com, Walmart.com, Jet.com and Dr. Tobias.com, with a plan to expand into other markets. For more information, visit Mimisrock.com.

Forward-Looking Informationv

Certain forward-looking statements contained in this news release that are based on the current expectations of management involve risks and uncertainties This ‘forward-looking information’, as the term is defined in applicable securities laws, includes, without limitation, the business and business results, goals, or outlook of Mimi’s Rock; risks associated with financial results and stability; development projects such as those referenced herein; sales to foreign jurisdictions; engineering and construction; production (including control over costs, quality, quantity, and timeliness of delivery); foreign currency and exchange rates; maintaining adequate working capital and raising further capital on acceptable terms or at all; and other similar statements concerning anticipated future events, conditions, or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions, and expectations; they are not guarantees of future performance. The Company cautions that all forward-looking information is inherently uncertain and a number of material factors, many of which are beyond the Company’s control, may affect actual performance. Accordingly, actual future events, conditions, and results may differ materially from the estimates, beliefs, intentions, and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this news release. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking, including those identified by the expressions ‘aim’, ‘anticipate’, ‘appear’, ‘believe’, ‘consider’, ‘could’, ‘estimate’, ‘expect’, ‘if’, ‘intend’, ‘goal’, ‘hope’, ‘likely’, ‘may’, ‘plan’, ‘possibly’, ‘potentially’, ‘pursue’, ‘seem’, ‘should’, ‘whether’, ‘will’, ‘would’, and similar expressions. Forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Except as required by law, Mimi’s Rock does not assume any obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Article Source: Web.Tmxmoney.com

View original content: Newswire.ca/News-Release

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO
905-350-5081
[email protected]

Jackie Kelly, Investor Relation
416-301-2949
[email protected] 

Source: Canada NewsWire

TORONTO, August 29, 2019 – Mimi’s Rock Corp. (TSXV:MIMI) “The Company”, an online dietary supplement and wellness company operating the Dr. Tobias brand, today announced its financial results for the quarter ended June 30, 2019.

For the three months ended June 30, 2019, the Company incurred a net loss of $1,240,051 compared to a net loss of $nil for the three months ended June 30, 2018. For the three months ended June 30, 2019, EBITDA was $460,008, compared to EBITDA of $nil for the three months ended June 30, 2018. Adjusted EBITDA, which excludes non-cash share based compensation expense, investment income and acquisition costs, was $1,382,117, compared to Adjusted EBITDA of $nil for the same period in the prior year. For the six months ended June 30, 2019, the Company incurred a net loss of $848,134 ($0.04 per share), compared to a net loss of $nil ($0.00 per share) for the six month period ended June 30, 2018. EBITDA for the six months ended June 30, 2019 was $1,557,921, compared to $nil EBITDA for the same period in the prior year. Adjusted EBITDA was $2,700,637 for the six months ended June 30, 2019, compared to $nil for the same period in 2018.

The Company reported a net loss for the three and six months ended June 30, 2019 primarily due to one-time costs related to its reverse takeover and public listing expenses as part of the Qualifying Transaction completed in May 2019, as well as non-cash share-based compensation expense. Tax expense in the period was also higher due to derecognition of tax loss carryforwards in Germany as a result of the reverse acquisition. During the second quarter, the Company began to generate sales from its own e-commerce site, drtobias.com, as well through additional online retail outlets. The Company also launched a private label brand in conjunction with its e-commerce channel partner.

Dave Kohler, CEO of Mimi’s Rock commented, “We are pleased that during the quarter, we executed three important strategic initiatives as planned. We added a new product family and opened a new online channel, in addition to launching our own e-Commerce site. Together, these accomplishments position us well to execute our scaling and expansionary plans.”

Revenues for the three months ended June 30, 2019 were $8,770,904, compared to $nil for the three months ended June 30, 2018, due to the acquisition of the DTI business in July 2018. Revenues represent sales of nutraceutical products in the U.S. market. Gross margin for the three months ended June 30, 2019 was $6,208,319 (70%) compared to $nil for the three month period ended June 30, 2018. Gross margin ratios have improved slightly on a quarter over quarter basis as the Company works with its supplier to obtain better pricing and efficiencies.

While the Company’s sales do not experience significant seasonality, there is some fluctuation on a quarterly basis due to natural demand fluctuation as well as promotional impacts. The Company continues to redevelop its brand strategy. As online advertising in the period was scaled back to evaluate returns on investment, sales volumes were somewhat lower while margins remained consistent.

The Company incurred selling and marketing expenses of $3,523,242, or approximately 40% of revenue, for the three months ended June 30, 2019, compared to $nil for the three months ended June 30, 2018. Sales and marketing expenses for the period consist primarily of fulfillment costs related to delivering products to customers, direct online advertising placements, costs related to marketing the Dr. Tobias brand and other promotional and awareness initiatives. The Company will continue to actively monitor its selling and marketing expenses, particularly those directly related to advertising and expects that these will increase in relation to sales revenues going forward.

General and administrative expenses for the three months ended June 30, 2019 were $1,302,960, compared to $nil for the same period in 2018. General and administrative expenses consist primarily of salaries and benefits, professional fees, occupancy costs and insurance. General and administrative expenses in the current period have normalized somewhat now that one-time costs associated with operational start-up and time and efforts spent engaged in understanding and integrating the DTI business have diminished. Share based compensation expense for the three months ended June 30, 2019 was $194,800 compared to $nil for the three months ended June 30, 2018. Share based compensation expense relates to awards under the Company’s incentive stock option plan and is based on the estimated number of awards that will eventually vest using the Black-Scholes option pricing model.

On May 27, 2019, the Company completed its Qualifying Transaction pursuant to an amalgamation agreement between the Company and Mimi’s Rock Inc. The Qualifying Transaction constituted a reverse take-over (“RTO”) for accounting purposes, as former MRI shareholders hold a majority of outstanding shares in the Company, the Board of Directors is comprised of MRI Board members and the senior management of MRI became senior management of the Company. Although the Company will be regarded as the legal parent, MRI is considered to be the acquirer for accounting purposes. Consequently, the Company is deemed to be a continuation of MRI. As a part of the Qualifying Transaction, the Company changed its name from “Commerce Acquisition Corp.” to “Mimi’s Rock Corp.”.

Listing expenses related to the acquisition and reverse takeover transaction for the three months ended June 30, 2019 were $697,787, compared to $nil for the same period in the prior year. Listing expenses consist primarily of legal, accounting and other professional fees associated with the reverse takeover and amalgamation, as well as non-cash costs related to equity instruments issued for the acquisition.

Interest and financing costs of $533,475 were incurred during the three months ended June 30, 2019, compared to $nil for the three months ended June 30, 2018. Interest and financing expenses in the current quarter include approximately $189,644 in non-cash charges related to amortization of expenses incurred in securing the Company’s senior secured loan, as well as $88,212 related to dividends in kind paid on the Preferred B shares prior to conversion in connection with the reverse takeover transaction.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company operating under the Dr. Tobias brand. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. Mimi’s Rock currently serves customers in the United States and has rapid growth plans to expand into other markets. For more information, visit Mimisrock.com.

Forward-Looking Information

This news release includes “forward-looking information,” as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO
905-350-5081
[email protected]

Jackie Kelly, Investor Relation
416-301-2949
[email protected] 

Source: Canada NewsWire

TORONTO , July 8, 2019 /CNW/ – Mimi’s Rock Corp. (MIMI.V) (‘The Company’), an online dietary supplement and wellness company operating the Dr. Tobias brand, is pleased to announce that it has entered into a Joint Venture Agreement with three-time world heavyweight champion Lennox Lewis to develop and commercialize a new line of branded nutritional supplements.

Lennox Lewis, nicknamed ‘The Lion’, is a retired professional boxer who remains the last heavyweight to hold the undisputed title. He competed from 1989 to 2003, and is a three-time world heavyweight champion and two-time Lineal champion. Holding dual British and Canadian citizenship, Lewis represented Canada as an amateur in the 1988 Summer Olympics, winning a gold medal in the super-heavyweight division.

The global fan base Lennox has attracted throughout the years, and the rapid growth of online sales and advertising create a massive opportunity to target customers with an interest in sports nutrition. On Facebook alone, there is an is an estimated audience of over 150 million active users who show an interest in boxing, with 71% being men and the remaining 29% women. The global dietary supplements market is growing at 10% CAGR for the period 2016-2024, according to Statista.com.

David Kohler, CEO ‘We are excited to partner with Lennox on this new family of products, which will focus on Health and Wellness for men. During his time in the ring and since, Lennox has remained much loved by his fans, likely because of the way he carried himself both inside and outside of the ring. He is an upbeat and inspiring athlete who has always taken tremendous care of his body. He is aligned with our values and focus on Wellness. We see significant synergies and the opportunity to positively impact lives with his influence.’

Mimi’s Rock will provide sourcing, distribution, channels, sales and marketing, and will obtain all regulatory approvals, in respect of the products. Lennox will grant to Mimi’s Rock a license to use his name and likeness, and will provide social media and marketing support in respect of the products. The License will be worldwide and will last for 36 months. The License will be exclusive to Mimi’s Rock in respect of the products and nutritional supplements that are reasonably expected to be competitive with the products. Significant marketing and branding decisions will require the unanimous approval of both parties. The transaction is subject to the execution of a definitive agreement..

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company operating under the Dr. Tobias brand. The brand features over 30 products including the top selling Colon Cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. The Omega 3 Fish Oil is also the 4th largest subscribe & save product on Amazon.com. Mimi’s Rock currently serves customers in the United States through Amazon.com, Walmart.com, and Dr. Tobias.com, with a rapid growth plan to expand into other markets. For more information, visit Mimisrock.com.

Forward-Looking Information

This news release includes certain forward-looking statements that are based upon the current expectations of management. Forward-looking statements involve risks and uncertainties This news release includes ‘forward-looking information,’ as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of Bloom Burton and its conference, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.associated with the businesses of Avivagen Inc., Mimi’s Rock Corp and the joint venture described above and the environment in which those businesses operate. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking, including those identified by the expressions ‘aim’, ‘anticipate’, ‘appear’, ‘believe’, ‘consider’, ‘could’, ‘estimate’, ‘expect’, ‘if’, ‘intend’, ‘goal’, ‘hope’, ‘likely’, ‘may’, ‘plan’, ‘possibly’, ‘potentially’, ‘pursue’, ‘seem’, ‘should’, ‘whether’, ‘will’, ‘would’ and similar expressions. Statements regarding the plan to sell product online through this joint venture, the potential for the joint venture to produce profits and other benefits that will be shared by Avivagen and Mimi’s Rock and the expected timing for product launch are forward looking statements. Forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. For instance, the products to be sold by the joint venture may not gain market acceptance or regulatory approval where required, leading to lower than expected profits and benefits and products may take longer to bring to market than currently anticipated, in each case due to many factors, many of which are outside of the control of the parties. Except as required by law, neither Avivagen nor Mimi’s Rock assumes any obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.

Article Source: Finance.yahoo.com/news

Original Content: Newswire.ca

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO
905-350-5081
[email protected]

Source: Canada NewsWire

TORONTO and OTTAWA, June 13, 2019 /CNW/ – Mimi’s Rock Corp. (TSXV:MIMI or ‘Mimi’s Rock’), an online dietary supplement and wellness company operating under the Dr. Tobias brand and with significant sales on the Amazon.com platform, and Avivagen Inc. (TSXV:VIV) (‘Avivagen’ or the ‘Corporation’), owner of the intellectual property protected OxC-beta™ technology that supports the optimal health of companion animals, are pleased to announce a Joint Venture agreement focused on the online sale of nutritional supplements for cats and dogs. Under the terms of the agreement, Avivagen will supply its products that include its proprietary OxC-beta™ technology and Mimi’s Rock will market and sell the product through its state of the art e-commerce platform and online global channels. This joint venture will be the exclusive channel through which Avivagen sells nutritional supplements for cats and dogs online. All sales will be conducted through a newly formed corporation jointly owned by Avivagen and Mimi’s Rock. The profits will be shared equally between the two companies.

Mimi’s Rock is an expert online marketer of brands for the human dietary supplement and wellness market, with a proprietary e-commerce site, significant sales via Amazon.com and other significant online channels and partners coming on-stream. Under the Dr. Tobias brand, owned by Mimi’s Rock, sales have grown at a compound annual rate of over 30%. Dave Kohler, CEO of Mimi’s Rock commented, ‘We have engaged with our customers, who care deeply about health and wellness and quality of products, and believe that the next product opportunity to serve their needs is in the growing companion animal market. We estimate that online sales of products for pets is a US$10.5 billion per year market globally and we believe that Avivagen’s OxC-beta™ technology will offer our customers unique, rigorously tested and scientifically backed products for the best care of their pets.’

Kym Anthony, CEO of Avivagen declared, ‘We believe that the deep scientific backing and testing, along with patents that cover our OxC-beta™ technology are ideally suited to make proprietary, exclusive and powerful products to provide their pet parents and that Mimi’s Rock has cracked the code of customer engagement and service to the next level. We have examined multiple partnering opportunities and we are both excited and delighted to be partnering with Mimi’s Rock, based on their deep knowledge of online marketing, significant traction across many products and a wonderful understanding of their customers’ needs.’

It is expected that a first product will be launched by the Joint Venture in the first quarter of 2020. The two companies will report further on the launch and progress in future public disclosures.

About Mimi’s Rock:

Mimi’s Rock Corp. operates an online dietary supplement and wellness company, with the primary brand being delivered as Dr. Tobias. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. Mimi’s Rock currently serves customers in the United States and has plans to expand into other markets. With an estimated value of $133 Billion in 2016, the global dietary supplements market is projected to accelerate at a rate of 9.6%, reaching over $278 Billion by 2024. The online market for pet products is estimated at US$10.5 billion.

About Avivagen:

Avivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance. It is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada and Charlottetown, Prince Edward Island. For more information, visit Avivagen.com. The contents of the website are expressly not incorporated by reference in this press release.

About OxC-beta™ Technology:

Avivagen’s OxC-beta™ technology is derived from Avivagen discoveries about carotenoids, compounds that give certain fruits and vegetables their bright colours, and is a non-antibiotic means of maintaining optimal health and growth.

Forward Looking Statements:

This news release includes certain forward-looking statements that are based upon the current expectations of management. Forward-looking statements involve risks and uncertainties associated with the businesses of Avivagen Inc., Mimi’s Rock Corp and the joint venture described above and the environment in which those businesses operate. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking, including those identified by the expressions ‘aim’, ‘anticipate’, ‘appear’, ‘believe’, ‘consider’, ‘could’, ‘estimate’, ‘expect’, ‘if’, ‘intend’, ‘goal’, ‘hope’, ‘likely’, ‘may’, ‘plan’, ‘possibly’, ‘potentially’, ‘pursue’, ‘seem’, ‘should’, ‘whether’, ‘will’, ‘would’ and similar expressions. Statements regarding the plan to sell product online through this joint venture, the potential for the joint venture to produce profits and other benefits that will be shared by Avivagen and Mimi’s Rock and the expected timing for product launch are forward looking statements. Forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. For instance, the products to be sold by the joint venture may not gain market acceptance or regulatory approval where required, leading to lower than expected profits and benefits and products may take longer to bring to market than currently anticipated, in each case due to many factors, many of which are outside of the control of the parties. Except as required by law, neither Avivagen nor Mimi’s Rock assumes any obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Article Source: Web.tmxmoney.com

Original Content: Newswire.ca

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO
905-350-5081
[email protected]

Source: Canada NewsWire

TORONTO, June 6, 2019 /CNW/ – Mimi’s Rock Corp. (TSXV:MIMI) ‘The Company’, an online dietary supplement and wellness company operating under the Dr. Tobias brand, is pleased to announce that it has launched its new e-commerce platform, developed by Commerce Dynamics.

‘We are thrilled to provide Mimi’s Rock a state of the art e-commerce platform to engage their users who have made Dr. Tobias a U.S. leader in the online sale of supplements and vitamins,’ says Kevin Smith, Senior Partner at Commerce Dynamics. ‘We have worked very hard over the last few months with the team at Mimi’s Rock to provide their customers, not only a great shopping experience, but a safe and scalable solution for all Dr. Tobias products.’

David Kohler, CEO of Mimi’s Rock Corp, states ‘I’m extremely pleased and excited to see the launch of our new site. It is important that we always focus on being available for our customers through whichever channel works best for them. Adding this important vehicle is an important step in furthering our customer engagement.’

The new e-commerce website will feature the full suite of Dr. Tobias products, and will ship within the United States. Offering an in-house platform will allow Mimi’s Rock to continue to monitor and improve their customer experience, analyze data patterns, and expand customer reach. The site will be both PC and mobile friendly.

About Commerce Dynamics:

Commerce Dynamics partners with world-class brands to further online success and transform customer engagement. Their solutions power brands with the technology to grow differently. For more information, visit https://www.commercedynamics.com/solutions.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company operating under the Dr. Tobias brand. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. Mimi’s Rock currently serves customers in the United States, and has rapid growth plans to expand into other markets. For more information, visit Mimisrock.com.

Forward Looking Information

This news release includes ‘forward-looking information,’ as such term is defined in applicable securities laws. Forward-looking information includes, without limitation, discussion of Bloom Burton and its conference, Mimi’s Rock Corp.’s business and business results, goals or outlook, risks associated with financial results and stability, development projects such as those referenced herein, sales to foreign jurisdictions, engineering and construction, production (including control over costs, quality, quantity and timeliness of delivery), foreign currency and exchange rates, maintaining adequate working capital and raising further capital on acceptable terms or at all, and other similar statements concerning anticipated future events, conditions or results that are not historical facts. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward looking information is inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. All statements are made as of the date of this news release and represent the Company’s judgement as of the date of this new release, and the Company is under no obligation to update or alter any forward-looking information.

Article Source: Web.tmxmoney.com

Original Content: Newswire.ca

Please Visit Mimisrock.com or Sedar.com for recent Mimi’s Rock Corp. filings.

For further information, please contact Mimi’s Rock Corp. at:

David Kohler, CEO
905-350-5081
[email protected]